Holen Sie sich die Stockscreener-App
410.93
2.47%
-12.18
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt HCA?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$423.11
Offen:
$418.88
24-Stunden-Volumen:
209.62K
Relative Volume:
0.15
Marktkapitalisierung:
$91.17B
Einnahmen:
$76.39B
Nettoeinkommen (Verlust:
$7.81B
KGV:
14.13
EPS:
29.0772
Netto-Cashflow:
$7.93B
1W Leistung:
+4.93%
1M Leistung:
+14.20%
6M Leistung:
-13.86%
1J Leistung:
+9.28%
1-Tages-Spanne:
$410.00
$418.88
1-Wochen-Bereich:
$395.10
$429.54
52-Wochen-Spanne:
$330.00
$556.52
Hca Healthcare Inc Stock (HCA) Company Profile
Firmenname
Hca Healthcare Inc
Sektor
Branche
Telefon
(615) 344-9551
Adresse
ONE PARK PLZ, NASHVILLE, TN
Compare HCA vs THC, DVA, FMS, EHC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HCA
Hca Healthcare Inc
|
410.99 | 93.86B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
204.31 | 17.99B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
233.47 | 15.04B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
23.91 | 13.00B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
109.08 | 10.98B | 6.07B | 793.80M | 464.40M | 5.9914 |
Hca Healthcare Inc Stock (HCA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-15 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-10-14 | Fortgesetzt | Goldman | Buy |
| 2025-07-28 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2025-07-16 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-05-29 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2025-04-15 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-12-17 | Fortgesetzt | JP Morgan | Neutral |
| 2024-11-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-11-22 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-09-03 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2024-01-04 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-12-11 | Herabstufung | Goldman | Buy → Neutral |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-04-19 | Fortgesetzt | JP Morgan | Neutral |
| 2022-07-06 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2022-03-29 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-01-10 | Fortgesetzt | Citigroup | Buy |
| 2021-12-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-24 | Eingeleitet | UBS | Buy |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-08-12 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Buy |
| 2021-05-13 | Fortgesetzt | Citigroup | Neutral |
| 2021-04-26 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-15 | Eingeleitet | Goldman | Buy |
| 2020-12-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-09-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-07-13 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2019-09-06 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-07-10 | Hochstufung | Goldman | Neutral → Buy |
| 2019-04-23 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2018-11-16 | Eingeleitet | UBS | Buy |
| 2018-03-23 | Fortgesetzt | Mizuho | Buy |
| 2018-01-03 | Eingeleitet | Goldman | Neutral |
| 2018-01-03 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-12-20 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2017-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2017-11-30 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2017-11-06 | Bestätigt | Citigroup | Neutral |
| 2017-11-01 | Bestätigt | Mizuho | Buy |
| 2017-07-26 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-06-28 | Eingeleitet | Argus | Buy |
Alle ansehen
Hca Healthcare Inc Aktie (HCA) Neueste Nachrichten
Swedbank AB Sells 5,716 Shares of HCA Healthcare, Inc. $HCA - MarketBeat
HCA Healthcare's Fall Shouldn't Be Construed As Failing Health - Seeking Alpha
Is HCA (HCA) Using Index Removal To Quietly Redefine Its Growth and Capital Allocation Playbook? - simplywall.st
CapEx per share of HCA Healthcare Inc – LS:A1JFMW - TradingView
Understanding the Setup: (HCA) and Scalable Risk - Stock Traders Daily
HCA Healthcare Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Can HCA's Capacity Expansion Strategy Fuel Its Long-Term Growth? - Yahoo Finance
HCA Maintained by Cantor Fitzgerald -- Price Target Lowered to $525 - GuruFocus
Ascension outbids HCA, Optum for Williamson Health - Modern Healthcare
Cantor Fitzgerald lowers HCA Healthcare price target to $528 on setup - Investing.com
HCA Healthcare explores long-term growth. US hospital operator focuses on operations and patient vol - AD HOC NEWS
How HCA Healthcare’s (HCA) Advanced Therapy Research Highlights Its High-Acuity Care Capabilities - Yahoo Finance
HCA Healthcare Inc. stock outperforms competitors on strong trading day - MarketWatch
HCA West Florida names new CEOs for Northside, Brandon hospitals - The Business Journals
If EPS Growth Is Important To You, HCA Healthcare (NYSE:HCA) Presents An Opportunity - Moomoo
HCA Healthcare, Inc. (HCA) Stock Analysis: A Robust 21.87% Upside Potential Awaits Investors - DirectorsTalk Interviews
HCA Healthcare Inc Actuals & Estimates (NYSE:HCA) - TradingView
Fideuram Intesa Sanpaolo Private Banking S.P.A. Trims Stock Position in HCA Healthcare, Inc. $HCA - MarketBeat
Elevation Point Wealth Partners LLC Has $10.03 Million Stock Position in HCA Healthcare, Inc. $HCA - MarketBeat
A Look at HCA Healthcare Inc (HCA) After 4.4% Gain -- GF Value $452.20 vs Price $410.50 - GuruFocus
HCA Healthcare Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
HCA Healthcare Jumps 5.2% Amid Sector-Wide Rally - AlphaStreet
HCA Healthcare Foundation awards grants to 89 Middle Tennessee nonprofits, advancing community health - HCA Healthcare Today
HCA Healthcare gains as investors weigh improving physician trends and a possible rebound after prior guidance-driven weakness - Quiver Quantitative
HCAHCA Healthcare Inc Options - Finviz
Cantor Fitzgerald reiterates HCA Healthcare stock rating on physician staffing - Investing.com
HCA Healthcare Earnings Preview: What to Expect - Barchart.com
Can HCA's Gene Therapy Milestone Drive Long-Term Growth? - Yahoo Finance
HCA Healthcare focuses on hospital operations as investors watch US care demand - AD HOC NEWS
HCA Healthcare (HCA) Reports Promising Gene-Editing Therapy Study Results - Insider Monkey
Cantor Fitzgerald reiterates HCA Healthcare stock rating at Overweight - Investing.com
Cantor Fitzgerald reiterates HCA Healthcare stock rating at Overweight By Investing.com - Investing.com Canada
HCA Healthcare (HCA): 12 Best Value Stocks to Buy Right Now - Insider Monkey
VivaScore partners with HCA Healthcare UK to extend the impact of health screening through cutting-edge digital platform - EIN Presswire
HCA Healthcare (HCA) Expands Pediatric Gene Editing Access After Journal Study - Yahoo Finance
HCA Healthcare (HCA) Stock After Recent Slide And DCF Upside Potential - Yahoo Finance
HCA Healthcare outlook holds steady as consensus focuses on margins - AD HOC NEWS
How Removal From Key Russell Growth Indexes Will Impact HCA Healthcare (HCA) Investors - Yahoo Finance
HCA DCF Analysis: Intrinsic Value $765 vs Price $392 - GuruFocus
HCA Healthcare (HCA) Has a Hospital Cash-Flow Engine Bigger Than a Labor-Cost Debate - AlphaStreet
HCA Healthcare Announces New England Journal of Medicine Study Highlighting Advances in CRISPR-based Therapy for Children - BioSpace
HCA Healthcare, Inc.(NYSE: HCA) dropped from Russell 1000 Growth-Defensive Index - marketscreener.com
HCA Announces Positive Results for Gene Editing Therapy in Child - GuruFocus
HCA Healthcare earnings calendar, NYSE-listed stock ahead of July report - AD HOC NEWS
HCA Healthcare announces New England Journal of Medicine study highlighting advances in CRISPR-based therapy for children - HCA Healthcare Today
HCA Healthcare Announces New England Journal of Medicine Study H - GuruFocus
HCA: Promising Gene-Editing Therapy Results for Pediatric Patien - GuruFocus
HCA Healthcare, Inc. (HCA) Investor Outlook: Exploring a 27.73% Potential Upside Amidst Steady Revenue Growth - DirectorsTalk Interviews
Index Exit And C-Suite Shift Could Be A Game Changer For HCA Healthcare (HCA) - simplywall.st
TriStar Centennial Medical Center - HCA Healthcare Today
HCA Healthcare, Inc.(NYSE: HCA) dropped from Russell 1000 Growth Benchmark - marketscreener.com
Finanzdaten der Hca Healthcare Inc-Aktie (HCA)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.26%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):